Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.68% |
| 2 | Technology | 12.88% |
| 3 | Consumer Staples | 9.84% |
| 4 | Communication Services | 9.02% |
| 5 | Financials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Vaalco Energy
EGY
$608M
| $3.42M | ﹤0.01% |
3,795,642
+48,452
| +1% | +$91.7K |
|
|
MTLS
1777
Materialise
MTLS
$400M
| $3.42M | ﹤0.01% |
184,300
-16,500
| -8% | -$285K |
|
|
BVH
1778
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $3.42M | ﹤0.01% |
295,755
+7,387
| +3% | +$126K |
|
|
ORBC
1779
DELISTED
ORBCOMM, Inc.
ORBC
| $3.41M | ﹤0.01% |
1,398,138
+1,150,018
| +463% | +$3.75M |
|
|
CAMP
1780
DELISTED
CalAmp Corp.
CAMP
| $3.4M | ﹤0.01% |
32,848
-12,426
| -27% | -$2.43M |
|
1781
iShares Silver Trust
SLV
$31.5B
| $3.38M | ﹤0.01% |
259,306
+46,506
| +22% | +$731K |
|
|
EIDX
1782
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $3.38M | ﹤0.01% |
69,001
+62,918
| +1,034% | +$3.21M |
|
1783
Compugen
CGEN
$228M
| $3.38M | ﹤0.01% |
464,900
-262,100
| -36% | -$2.06M |
|
1784
Northeast Bank
NBN
$1.15B
| $3.37M | ﹤0.01% |
289,345
-24,400
| -8% | -$442K |
|
|
MASI
1785
DELISTED
Masimo
MASI
| $3.37M | ﹤0.01% |
19,000
-7,021
| -27% | -$1.2M |
|
|
VSA
1786
VisionSys AI
VSA
$9.27M
| $3.35M | ﹤0.01% |
350
-70
| -17% | -$520K |
|
1787
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.4B
| $3.35M | ﹤0.01% |
+47,500
| New | +$3.22M |
|
1788
Monarch Casino & Resort
MCRI
$2.22B
| $3.34M | ﹤0.01% |
119,103
-86,500
| -42% | -$3.79M |
|
|
EXTN
1789
DELISTED
Exterran Corporation
EXTN
| $3.34M | ﹤0.01% |
696,300
-44,800
| -6% | -$269K |
|
|
SAFE
1790
DELISTED
Safehold Inc.
SAFE
| $3.34M | ﹤0.01% |
+52,800
| New | +$2.67M |
|
1791
Edgewell Personal Care
EPC
$1.31B
| $3.33M | ﹤0.01% |
138,500
-134,300
| -49% | -$4.01M |
|
|
JNCE
1792
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.33M | ﹤0.01% |
700,114
+290,200
| +71% | +$1.67M |
|
|
CFMS
1793
DELISTED
Conformis, Inc. Common Stock
CFMS
| $3.32M | ﹤0.01% |
210,610
+12,235
| +6% | +$299K |
|
|
KNL
1794
DELISTED
Knoll, Inc.
KNL
| $3.32M | ﹤0.01% |
321,441
-32,959
| -9% | -$656K |
|
1795
Schneider National
SNDR
$6.33B
| $3.31M | ﹤0.01% |
171,200
-245,500
| -59% | -$5.09M |
|
1796
Liberty Latin America Class A
LILA
$1.69B
| $3.31M | ﹤0.01% |
491,451
-29,094
| -6% | -$293K |
|
1797
Aclaris Therapeutics
ACRS
$851M
| $3.3M | ﹤0.01% |
3,175,636
+393,339
| +14% | +$535K |
|
|
TSC
1798
DELISTED
TriState Capital Holdings, Inc.
TSC
| $3.3M | ﹤0.01% |
341,623
+110,923
| +48% | +$2.22M |
|
1799
Natural Alternatives International
NAII
$12.8M
| $3.3M | ﹤0.01% |
524,121
-25,477
| -5% | -$191K |
|
|
ARCE
1800
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $3.3M | ﹤0.01% |
78,000
-80,500
| -51% | -$3.99M |
|
Similar funds
Jim Simons's Q1 2020 Portfolio in Review
As of Q1 2020, Jim Simons held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jim Simons's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Jim Simons added most to Baidu in Q1 2020, an estimated $462M increase.
- Jim Simons's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Jim Simons fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Jim Simons's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Jim Simons opened 573 new positions and closed 645 in Q1 2020.
- Jim Simons's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.